Marshall Wace North America’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-486,895
Closed -$41M – 1572
2021
Q2
$41M Buy
486,895
+57,189
+13% +$4.77M 0.17% 129
2021
Q1
$34.9M Buy
+429,706
New +$36.7M 0.14% 165
2020
Q2
– Sell
-4,272
Closed -$313K – 1301
2020
Q1
$313K Sell
4,272
-354,398
-99% -$26.8M ﹤0.01% 845
2019
Q4
$31.3M Sell
358,670
-23,684
-6% -$2.02M 0.15% 164
2019
Q3
$28.4M Buy
382,354
+157,893
+70% +$12.8M 0.16% 141
2019
Q2
$19.1M Buy
+224,461
New +$18M 0.12% 154
2017
Q4
– Sell
-3,708
Closed -$434K – 1472
2017
Q3
$434K Sell
3,708
-173,648
-98% -$22M ﹤0.01% 1093
2017
Q2
$22.3M Sell
177,356
-158,022
-47% -$20.1M 0.16% 162
2017
Q1
$44.9M Buy
+335,378
New +$42.7M 0.35% 81
2013
Q4
$1.89M Buy
+37,258
New +$1.62M 0.04% 303

Other funds holding INCY

Marshall Wace North America's INCY Position: Q3 2021 in Review

Marshall Wace North America sold out of Incyte (INCY) in Q3 2021, closing a stake of 486,895 shares — an estimated $41M sold.

Marshall Wace North America first reported a position in INCY in Q4 2013 and held it in 10 quarters. The position peaked at $44.9M in Q1 2017. 494 funds tracked by Wall St. Rank hold INCY as of Q3 2021.

  • Marshall Wace North America reported no remaining Incyte position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 486,895 Incyte shares in Q3 2021, an estimated $41M.
  • Marshall Wace North America first reported a position in Incyte in Q4 2013 and held it in 10 quarters.
  • Marshall Wace North America's Incyte position peaked at $44.9M in Q1 2017.
  • 494 funds tracked by Wall St. Rank held Incyte as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.